Skip to main content
. 2024 Jul 12;79(9):glae175. doi: 10.1093/gerona/glae175

Table 2.

Baseline Characteristics for Each Trajectory Group

n Overall Sample No/Rare LBP Low Frequency-Stable LBP Low Frequency-Increasing LBP Moderate Frequency-LBP High Frequency-Stable LBP
(N = 5 976) (N = 2 442) (N = 1 040) (N = 719) (N = 745) (N = 1 030)
Age 5 976 74.14 ± 5.88 74.06 ± 5.99 74.52 ± 5.62 74.20 ± 5.93 73.72 ± 5.75 74.23 ± 5.90
White race 5 976 5 346 (89.46) 2 167 (88.74) 908 (87.31) 655 (91.10) 679 (91.14) 937 (90.97)
Body mass index 5 969 27.38 ± 3.83 27.06 ± 3.69 27.15 ± 3.67 27.75 ± 3.96 27.56 ± 3.91 28.00 ± 4.08
Education (high school+) 5 976 5 585 (93.46) 2 304 (94.35) 981 (94.33) 670 (93.18) 684 (91.81) 946 (91.84)
Depressive symptoms 5 975 296 (4.95) 102 (4.18) 61 (5.87) 37 (5.15) 39 (5.23) 57 (5.53)
Greater/equal to 1 alcoholic drink per week 5 968 3 113 (52.16) 1 298 (53.24) 547 (52.60) 398 (55.51) 384 (51.61) 486 (47.23)
Current smoker 5 975 206 (3.45) 74 (3.03) 39 (3.75) 23 (3.20) 31 (4.16) 39 (3.79)
Lives alone 5 976 835 (13.97) 318 (13.02) 149 (14.33) 113 (15.72) 108 (14.50) 147 (14.27)
Married 5 976 4 918 (82.30) 2 038 (83.46) 853 (82.02) 573 (79.69) 616 (82.68) 838 (81.36)
Arthritis (body) or gout 5 976 2 834 (47.42) 906 (37.10) 454 (43.65) 374 (52.02) 408 (54.77) 692 (67.18)
Arthritis (low back) 5 976 970 (16.23) 140 (5.73) 137 (13.17) 118 (16.41) 148 (19.87) 427 (41.46)
COPD 5 976 637 (10.66) 187 (7.66) 121 (11.63) 75 (10.43) 92 (12.35) 162 (15.73)
CVD (MI, stroke, or angina) 5 976 1 626 (27.21) 549 (22.48) 278 (26.73) 213 (29.62) 230 (30.87) 356 (34.56)
Diabetes 5 976 651 (10.89) 238 (9.75) 117 (11.25) 87 (12.10) 81 (10.87) 128 (12.43)
Cancer (nonskin) 5 976 1 088 (18.21) 426 (17.44) 200 (19.23) 130 (18.08) 130 (17.45) 202 (19.61)
Fall in last 12 months 5 976 1 262 (21.12) 403 (16.50) 240 (23.08) 153 (21.28) 179 (24.03) 287 (27.86)
Fracture since age 50 5 976 98 (1.64) 35 (1.43) 13 (1.25) 15 (2.09) 15 (2.01) 20 (1.94)
Antidepressant use 5 635 351 (6.23) 86 (3.76) 56 (5.79) 57 (8.28) 57 (8.05) 95 (9.68)
Benzodiazepine use 5 740 205 (3.57) 58 (2.48) 30 (3.04) 30 (4.30) 23 (3.20) 64 (6.42)
Opioid use 5 740 158 (2.75) 21 (0.90) 16 (1.62) 13 (1.87) 25 (3.48) 83 (8.32)
NSAID use 5 740 888 (15.47) 224 (9.57) 133 (13.48) 118 (16.93) 133 (18.52) 280 (28.08)
ADL limitation 5 976 830 (13.89) 185 (7.58) 120 (11.54) 110 (15.30) 129 (17.32) 286 (27.77)
IADL limitation (y/n) 5 976 845 (14.14) 186 (7.62) 116 (11.15) 107 (14.88) 138 (18.52) 298 (28.93)
Narrow walk-in m/s using best time 5 421 1.15 ± 0.27 1.16 ± 0.26 1.15 ± 0.26 1.15 ± 0.28 1.14 ± 0.27 1.10 ± 0.27
Walk speed in m/s using both times 5 964 1.20 ± 0.23 1.22 ± 0.22 1.21 ± 0.22 1.20 ± 0.22 1.20 ± 0.23 1.15 ± 0.24
PASE Score 5 973 146.50 ± 68.16 150.30 ± 69.58 145.04 ± 65.23 144.80 ± 69.06 146.53 ± 68.82 140.10 ± 66.03
Max of L/R grip strength, KG 5 862 41.63 ± 8.50 41.72 ± 8.33 41.54 ± 8.47 41.72 ± 8.57 41.50 ± 8.69 41.57 ± 8.75
Chair stands per 10 s (those unable/refused = 0) 5 953 4.73 ± 1.52 4.91 ± 1.47 4.72 ± 1.51 4.71 ± 1.44 4.63 ± 1.54 4.39 ± 1.61
Nottingham maximum power, both legs, watts 5 426 208.46 ± 63.08 209.58 ± 62.97 206.39 ± 64.36 212.93 ± 61.96 209.35 ± 63.45 203.83 ± 62.26
Total number of meds: (0, 1–3 or 4+) 672 (11.93) 344 (15.02) 125 (12.91) 73 (10.61) 74 (10.45) 56 (5.71)
5 635 2 164 (38.40) 985 (43.01) 373 (38.53) 230 (33.43) 257 (36.30) 319 (32.52)
2 799 (49.67) 961 (41.97) 470 (48.55) 385 (55.96) 377 (53.25) 606 (61.77)
Cognitive impairment trails B (>1.5 SD above mean) 5 835 541 (9.27) 215 (9.01) 84 (8.29) 66 (9.36) 75 (10.29) 101 (10.07)
Cognitive impairment, Teng 100 (<80) 5 972 167 (2.80) 66 (2.70) 33 (3.17) 12 (1.67) 26 (3.49) 30 (2.92)
SF-12 modified mental sum scale (median split) 5 973 2 985 (49.97) 1 079 (44.22) 556 (53.51) 386 (53.69) 388 (52.08) 576 (55.92)
SF-12 modified physical sum scale (median split) 5 973 2 976 (49.82) 864 (35.41) 502 (48.32) 377 (52.43) 466 (62.55) 767 (74.47)

Notes: ALD = activities of daily living; IADL = instrumental activities of daily living; COPD = chronic obstructive pulmonary disease; CVD = cardiovascular disease; LBP = low back pain; NSAID = non-steroidal anti-inflammatory.